Ebpay生命医药出版社

Ebpay生命

100763

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

局部肿瘤破坏/切除与全子宫切除术治疗 IA 期宫颈癌的长期结局:基于 SEER 数据库的回顾性研究

 

Authors Chang LL, Wang YQ, Zhang XM, Liu J, Zang LL, Li L, Luo L, Zhu F, Zhu MX, Zhang HQ, Kang YX, Lin L, Wu ZC, Xu Q 

Received 12 August 2024

Accepted for publication 22 February 2025

Published 10 March 2025 Volume 2025:17 Pages 711—725

DOI http://doi.org/10.2147/IJWH.S491112

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Marleen van Gelder

Le-Le Chang,1,* Yu-Qin Wang,1,* Xue-Mei Zhang,2,* Jing Liu,1 Le-Le Zang,1 Li Li,1 Lan Luo,1 Fei Zhu,1 Ming-Xuan Zhu,1 Hui-Qi Zhang,1 Ya-Xin Kang,1 Ling Lin,1,3 Zhi-Cong Wu,4 Qin Xu1 

1Departments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, Fujian, 350014, People’s Republic of China; 2Department of Radiation Oncology, Quzhou People’s Hospital, Quzhou, Zhejiang, 323000, People’s Republic of China; 3Fujian Medical University, Fuzhou, Fujian, 350014, People’s Republic of China; 4Gynecology Department, The First Hospital of PuTian City, Putian, Fujian, 351100, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Qin Xu; Zhi-cong Wu, Email xuqin@fjmu.edu.cn; wzc122617@qq.com

Background: A growing number of patients with early-stage cervical cancer opt for local tumor resection to preserve the uterus. Nevertheless, there is still a dearth of long-term comparisons between local tumor destruction/excision (LTD/LTE) and total hysterectomy(TH), and the optimal target population for local tumor excision remains uncertain.
Methods: A multicenter retrospective study utilizing the Surveillance, Epidemiology, and End Results (SEER) database to compare the long-term outcomes between LTD/LTE and TH in stage IA cervical cancer patients was conducted. A 1:1 propensity score matching (PSM) method was employed to obtain matched cohorts with similar baseline characteristics in the LTD/LTE and TH groups. Kaplan-Meier analysis was used to compare overall survival (OS) and cancer-specific survival (CSS) between the two groups. The Cox proportional hazard models were employed to identify factors associated with OS and CSS.
Results: This study comprised a total of 6382 cervical cancer patients, with 1759 undergoing LTD/LTE and 4623 undergoing TH. After PSM, a significant difference was observed in OS (P=0.030) between the two groups, while no significant difference was found in CSS (P=0.110). Subgroup analysis of patients with stage IA1 (OS: P=0.018; CSS: P=0.230) and IA2 (OS: P=0.071; CSS: P=0.240) revealed no significant differences in OS and CSS between the two groups. Older age (≥ 50 years) [HR=2.20; 95% CI: 2.20– 3.30)] and histological types other than squamous cell carcinoma and usual-type adenocarcinoma [HR=4.40; 95% CI:1.80– 11.10] favored TH for better OS, whereas well-differentiated (grade I–II) [HR=0.40; 95% CI: 0.20– 0.90] patients were more suitable for LTD/LTE, leading to improved OS and CSS outcomes.
Conclusion: It was determined that the long-term outcomes of LTD/LTE are comparable to TH and can serve as a safe option for selected patients with stage IA cervical cancer. Future large prospective studies are required to validate our findings and explore differences in recurrence patterns between the two treatment strategies.

Keywords: cervical cancer, local tumor destruction/excision, total hysterectomy, propensity score matching analysis, SEER database, long-term outcomes

Download Article[PDF]